Literature DB >> 25246568

The cardiac-specific N-terminal region of troponin I positions the regulatory domain of troponin C.

Peter M Hwang1, Fangze Cai2, Sandra E Pineda-Sanabria2, David C Corson2, Brian D Sykes2.   

Abstract

The cardiac isoform of troponin I (cTnI) has a unique 31-residue N-terminal region that binds cardiac troponin C (cTnC) to increase the calcium sensitivity of the sarcomere. The interaction can be abolished by cTnI phosphorylation at Ser22 and Ser23, an important mechanism for regulating cardiac contractility. cTnC contains two EF-hand domains (the N and C domain of cTnC, cNTnC and cCTnC) connected by a flexible linker. Calcium binding to either domain favors an "open" conformation, exposing a large hydrophobic surface that is stabilized by target binding, cTnI[148-158] for cNTnC and cTnI[39-60] for cCTnC. We used multinuclear multidimensional solution NMR spectroscopy to study cTnI[1-73] in complex with cTnC. cTnI[39-60] binds to the hydrophobic face of cCTnC, stabilizing an alpha helix in cTnI[41-67] and a type VIII turn in cTnI[38-41]. In contrast, cTnI[1-37] remains disordered, although cTnI[19-37] is electrostatically tethered to the negatively charged surface of cNTnC (opposite its hydrophobic surface). The interaction does not directly affect the calcium binding affinity of cNTnC. However, it does fix the positioning of cNTnC relative to the rest of the troponin complex, similar to what was previously observed in an X-ray structure [Takeda S, et al. (2003) Nature 424(6944):35-41]. Domain positioning impacts the effective concentration of cTnI[148-158] presented to cNTnC, and this is how cTnI[19-37] indirectly modulates the calcium affinity of cNTnC within the context of the cardiac thin filament. Phosphorylation of cTnI at Ser22/23 disrupts domain positioning, explaining how it impacts many other cardiac regulatory mechanisms, like the Frank-Starling law of the heart.

Entities:  

Keywords:  dilated cardiomyopathy; fuzzy complex; heart failure; hypertrophic cardiomyopathy; post-translational modification

Mesh:

Substances:

Year:  2014        PMID: 25246568      PMCID: PMC4210035          DOI: 10.1073/pnas.1410775111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Composite low affinity interactions dictate recognition of the cyclin-dependent kinase inhibitor Sic1 by the SCFCdc4 ubiquitin ligase.

Authors:  Xiaojing Tang; Stephen Orlicky; Tanja Mittag; Veronika Csizmok; Tony Pawson; Julie D Forman-Kay; Frank Sicheri; Mike Tyers
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-10       Impact factor: 11.205

2.  Dynamic equilibrium engagement of a polyvalent ligand with a single-site receptor.

Authors:  Tanja Mittag; Stephen Orlicky; Wing-Yiu Choy; Xiaojing Tang; Hong Lin; Frank Sicheri; Lewis E Kay; Mike Tyers; Julie D Forman-Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-13       Impact factor: 11.205

Review 3.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies.

Authors:  Kavita Sharma; David A Kass
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

4.  Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart.

Authors:  R J Solaro; A J Moir; S V Perry
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

5.  Mapping of a second actin-tropomyosin and a second troponin C binding site within the C terminus of troponin I, and their importance in the Ca2+-dependent regulation of muscle contraction.

Authors:  B Tripet; J E Van Eyk; R S Hodges
Journal:  J Mol Biol       Date:  1997-09-05       Impact factor: 5.469

6.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

7.  Why does troponin I have so many phosphorylation sites? Fact and fancy.

Authors:  R John Solaro; Jolanda van der Velden
Journal:  J Mol Cell Cardiol       Date:  2010-02-25       Impact factor: 5.000

Review 8.  Integration of troponin I phosphorylation with cardiac regulatory networks.

Authors:  R John Solaro; Marcus Henze; Tomoyoshi Kobayashi
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

9.  The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated.

Authors:  J Wattanapermpool; X Guo; R J Solaro
Journal:  J Mol Cell Cardiol       Date:  1995-07       Impact factor: 5.000

10.  Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.

Authors:  Nazha Hamdani; Walter J Paulus; Loek van Heerebeek; Attila Borbély; Nicky M Boontje; Marian J Zuidwijk; Jean G F Bronzwaer; Warner S Simonides; Hans W M Niessen; Ger J M Stienen; Jolanda van der Velden
Journal:  Eur Heart J       Date:  2009-05-31       Impact factor: 29.983

View more
  26 in total

1.  Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation.

Authors:  Mohit Kumar; Suresh Govindan; Mengjie Zhang; Ramzi J Khairallah; Jody L Martin; Sakthivel Sadayappan; Pieter P de Tombe
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

Review 2.  The missing links within troponin.

Authors:  Mayra A Marques; Michelle S Parvatiyar; Wei Yang; Guilherme A P de Oliveira; Jose R Pinto
Journal:  Arch Biochem Biophys       Date:  2018-12-22       Impact factor: 4.013

Review 3.  Biophysical Derangements in Genetic Cardiomyopathies.

Authors:  Melissa L Lynn; Sarah J Lehman; Jil C Tardiff
Journal:  Heart Fail Clin       Date:  2018-04       Impact factor: 3.179

4.  Changes in the dynamics of the cardiac troponin C molecule explain the effects of Ca2+-sensitizing mutations.

Authors:  Charles M Stevens; Kaveh Rayani; Gurpreet Singh; Bairam Lotfalisalmasi; D Peter Tieleman; Glen F Tibbits
Journal:  J Biol Chem       Date:  2017-05-22       Impact factor: 5.157

5.  Functional communication between PKC-targeted cardiac troponin I phosphorylation sites.

Authors:  Sarah E Lang; Tamara K Stevenson; Tabea M Schatz; Brandon J Biesiadecki; Margaret V Westfall
Journal:  Arch Biochem Biophys       Date:  2017-06-03       Impact factor: 4.013

Review 6.  Structure and function of cardiac troponin C (TNNC1): Implications for heart failure, cardiomyopathies, and troponin modulating drugs.

Authors:  Monica X Li; Peter M Hwang
Journal:  Gene       Date:  2015-07-29       Impact factor: 3.688

7.  FRET-based analysis of the cardiac troponin T linker region reveals the structural basis of the hypertrophic cardiomyopathy-causing Δ160E mutation.

Authors:  Salwa Abdullah; Melissa L Lynn; Mark T McConnell; Matthew M Klass; Anthony P Baldo; Steven D Schwartz; Jil C Tardiff
Journal:  J Biol Chem       Date:  2019-08-06       Impact factor: 5.157

8.  '(De-)sensitization' vs. 'Uncoupling': what drives cardiomyopathies in the thin filament? Reply.

Authors:  Steven Marston; Andrew Messer; Maria Papadaki
Journal:  Cardiovasc Res       Date:  2015-10-13       Impact factor: 10.787

Review 9.  Order-Disorder Transitions in the Cardiac Troponin Complex.

Authors:  Lauren Ann Metskas; Elizabeth Rhoades
Journal:  J Mol Biol       Date:  2016-07-06       Impact factor: 5.469

Review 10.  Physiological and pathological roles of protein kinase A in the heart.

Authors:  Yuening Liu; Jingrui Chen; Shayne K Fontes; Erika N Bautista; Zhaokang Cheng
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.